Adverse reactions to xenon-enhanced CT cerebral blood flow determination

Richard E Latchaw, H. Yonas, S. L. Pentheny, D. Gur

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Fourteen institutions performed 1,830 computed tomographic (CT) cerebral blood flow (CBF) examinations with 32% inhaled stable xenon. Respiratory rate delay greater than 10 seconds occurred in 3.6% of patients, with 83% of the delays lasting 10-15 seconds. There was no incident of prolonged respiratory difficulty. Headache (0.4%), seizures (0.2%), nausea and vomiting (0.2%), and change in neurologic status (0.1%) were uncommon, and there were no transient ischemic attacks. The CT CBF method with 32% inhaled stable xenon is thus associated with an acceptably low incidence of adverse reactions.

Original languageEnglish (US)
Pages (from-to)251-254
Number of pages4
JournalRadiology
Volume163
Issue number1
StatePublished - 1987
Externally publishedYes

Fingerprint

Cerebrovascular Circulation
Xenon
Transient Ischemic Attack
Respiratory Rate
Nausea
Nervous System
Vomiting
Headache
Seizures
Incidence

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Latchaw, R. E., Yonas, H., Pentheny, S. L., & Gur, D. (1987). Adverse reactions to xenon-enhanced CT cerebral blood flow determination. Radiology, 163(1), 251-254.

Adverse reactions to xenon-enhanced CT cerebral blood flow determination. / Latchaw, Richard E; Yonas, H.; Pentheny, S. L.; Gur, D.

In: Radiology, Vol. 163, No. 1, 1987, p. 251-254.

Research output: Contribution to journalArticle

Latchaw, RE, Yonas, H, Pentheny, SL & Gur, D 1987, 'Adverse reactions to xenon-enhanced CT cerebral blood flow determination', Radiology, vol. 163, no. 1, pp. 251-254.
Latchaw, Richard E ; Yonas, H. ; Pentheny, S. L. ; Gur, D. / Adverse reactions to xenon-enhanced CT cerebral blood flow determination. In: Radiology. 1987 ; Vol. 163, No. 1. pp. 251-254.
@article{e06100b44b58485497d7a7fa57892c63,
title = "Adverse reactions to xenon-enhanced CT cerebral blood flow determination",
abstract = "Fourteen institutions performed 1,830 computed tomographic (CT) cerebral blood flow (CBF) examinations with 32{\%} inhaled stable xenon. Respiratory rate delay greater than 10 seconds occurred in 3.6{\%} of patients, with 83{\%} of the delays lasting 10-15 seconds. There was no incident of prolonged respiratory difficulty. Headache (0.4{\%}), seizures (0.2{\%}), nausea and vomiting (0.2{\%}), and change in neurologic status (0.1{\%}) were uncommon, and there were no transient ischemic attacks. The CT CBF method with 32{\%} inhaled stable xenon is thus associated with an acceptably low incidence of adverse reactions.",
author = "Latchaw, {Richard E} and H. Yonas and Pentheny, {S. L.} and D. Gur",
year = "1987",
language = "English (US)",
volume = "163",
pages = "251--254",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "1",

}

TY - JOUR

T1 - Adverse reactions to xenon-enhanced CT cerebral blood flow determination

AU - Latchaw, Richard E

AU - Yonas, H.

AU - Pentheny, S. L.

AU - Gur, D.

PY - 1987

Y1 - 1987

N2 - Fourteen institutions performed 1,830 computed tomographic (CT) cerebral blood flow (CBF) examinations with 32% inhaled stable xenon. Respiratory rate delay greater than 10 seconds occurred in 3.6% of patients, with 83% of the delays lasting 10-15 seconds. There was no incident of prolonged respiratory difficulty. Headache (0.4%), seizures (0.2%), nausea and vomiting (0.2%), and change in neurologic status (0.1%) were uncommon, and there were no transient ischemic attacks. The CT CBF method with 32% inhaled stable xenon is thus associated with an acceptably low incidence of adverse reactions.

AB - Fourteen institutions performed 1,830 computed tomographic (CT) cerebral blood flow (CBF) examinations with 32% inhaled stable xenon. Respiratory rate delay greater than 10 seconds occurred in 3.6% of patients, with 83% of the delays lasting 10-15 seconds. There was no incident of prolonged respiratory difficulty. Headache (0.4%), seizures (0.2%), nausea and vomiting (0.2%), and change in neurologic status (0.1%) were uncommon, and there were no transient ischemic attacks. The CT CBF method with 32% inhaled stable xenon is thus associated with an acceptably low incidence of adverse reactions.

UR - http://www.scopus.com/inward/record.url?scp=0023144262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023144262&partnerID=8YFLogxK

M3 - Article

C2 - 3823444

AN - SCOPUS:0023144262

VL - 163

SP - 251

EP - 254

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 1

ER -